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Background: Although the importance of proteins of the biomineral organic matrix and their posttranslational
modifications for biomineralization is generally recognized, the number of published matrix proteomes is still small.
This is mostly due to the lack of comprehensive sequence databases, usually derived from genomic sequencing
projects. However, in-depth mass spectrometry-based proteomic analysis, which critically depends on high-quality
sequence databases, is a very fast tool to identify candidates for functional biomineral matrix proteins and their
posttranslational modifications. Identification of such candidate proteins is facilitated by at least approximate
quantitation of the identified proteins, because the most abundant ones may also be the most interesting candidates
for further functional analysis.
Results: Re-quantification of previously identified Lottia shell matrix proteins using the intensity-based absolute
quantification (iBAQ) method as implemented in the MaxQuant identification and quantitation software showed
that only 57 of the 382 accepted identifications constituted 98% of the total identified matrix proteome. This
group of proteins did not contain obvious intracellular proteins, such as cytoskeletal components or ribosomal
proteins, invariably identified as minor components of high-throughput biomineral matrix proteomes. Fourteen of
these major proteins were phosphorylated to a variable extent. All together we identified 52 phospho sites in 20
of the 382 accepted proteins with high confidence.
Conclusions: We show that iBAQ quantitation may be a useful tool to narrow down the group of functional
biomineral matrix protein candidates for further research in cell biology, genetics or materials research. Knowledge
of posttranslational modifications in these major proteins could be a valuable addition to previously published
proteomes. This is true especially for phosphorylation, because this modification was already shown to modify
mineralization processes in some instances.Introduction
Phosphorylation is one of the most widespread post-
translational modifications of proteins and also occurs in
the organic matrix of biominerals [1,2]. Protein FAM20C
has recently been identified as a kinase involved in phos-
phorylation of such secreted proteins [3,4], but other
kinases may also be involved [5,6]. In a few cases experi-
mental evidence indicated an important function for
phospho groups in biomineral matrix proteins. The
best-examined matrix phosphoprotein in this respect is* Correspondence: mann@biochem.mpg.de
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article, unless otherwise stated.mammalian osteopontin, first described as a major non-
collagenous bone protein. Among the many functions
suggested for this protein since its discovery (reviewed, for
instance, in [7,8]) is also phosphorylation-dependent in-
hibition of mineralization processes [9]. Removal of phos-
pho groups by alkaline phosphatase significantly reduces
its inhibitory potential in in vitro crystallization assays [10]
and un-phosphorylated recombinant osteopontin, but
not in vitro phosphorylated osteopontin, fails to inhibit
mineralization of human smooth muscle cell cultures
serving as a model for human vascular calcification
[11]. A crucial role of phosphorylated residues in the
interaction with mineral is also reported for dentin
matrix protein 1 and dentin phosphophoryn [12,13].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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major matrix protein from crustacean calcium storage
structures. Phosphorylation of orchestin is necessary for
calcium binding of the protein [14].
The recently published genomes of biomineralizing
organisms enable high-throughput mass spectrometry-
based analysis of biomineral proteomes and phospho-
proteomes, thus facilitating the fast identification of
phosphoproteins and phosphorylation sites [15,16]. In
the present study we add the phosphoproteome of the
Lottia gigantea shell matrix to the recently published
Lottia shell proteomes [17,18]. Furthermore, we have
re-quantitated the Lottia shell proteome using the iBAQ
(intensity-based absolute quantification) method [19] as
implemented in MaxQuant. This showed that 57 pro-
teins make up 98% of the total identified proteome. We
suggest that quantitation allows the identification of
major proteins, which are the most likely candidates for
functional shell proteins, while retaining information
about minor proteins, irrespective of whether these minor
proteins play a role in mineralization or not, and irrespect-
ive of whether they occur intra- or extra-crystalline.
Materials and methods
Matrix and phosphopeptide preparation
Lottia shell matrix was prepared as previously described
[17] using method B for shell cleaning (2 h sodium
hypochlorite incubation with 2 × 5 min ultrasound treat-
ment). Reduction, carbamidomethylation and enzymatic
cleavage of matrix proteins were performed using a
modification of the FASP (Filter-aided sample prepar-
ation) method [20] as outlined below. Two-mg aliquots
of acid-soluble or acid-insoluble shell matrix were sus-
pended in 300 μl of 0.1 M Tris, pH8, containing 6 M
guanidine hydrochloride and 0.01 M dithiothreitol (DTT).
This mixture was heated to 56°C for 60 min, cooled to
room temperature, and centrifuged at 13000 rpm in an
Eppendorf bench-top centrifuge 5415D for 15 min. The
supernatant was loaded into an Amicon Ultra 0.5 ml 30 K
filter device (Millipore; Tullagreen, Ireland). DTT was
removed by centrifugation at 13000 rpm for 15 min and
washing with 2 × 1vol of the same buffer. Carbami-
domethylation was done in the device using 0.1 M Tris
buffer, pH8, containing 6 M-guanidine hydrochloride and
0.05 mM iodoacetamide and incubation for 45 min in the
dark. Carbamidomethylated proteins were washed with
0.05 M ammonium hydrogen carbonate buffer, pH8, con-
taining 2 M urea, and centrifugation as before. Trypsin
(20 μg, Sequencing grade, modified; Promega, Madison,
USA) was added in 40 μl of 0.05 M ammonium hydrogen
carbonate buffer containing 2 M urea and the devices
were incubated at 37°C for 16 h. Peptides were collected
by centrifugation and the filters were washed twice with
40 μl of 0.05 M ammonium hydrogen carbonate buffer.The peptide solution was acidified to pH 1–2 with trifluor-
oacetic acid (TFA) and peptides were vacuum-dried in an
Eppendorf concentrator.
Phosphopeptides were enriched by reversible binding
to TiO2 beads (Titansphere 10 μm, GL Sciences, Japan)
following established protocols [21] but substituting
2,5-dihydroxybenzoic acid in the loading buffer by 6%
trifluoroacetic acid (TFA) [22]. Briefly, beads were washed
first in 80% acetonitrile containing 0.1% TFA (washing
buffer), then in 80% acetonitrile containing 6% TFA (bind-
ing buffer). Peptides were dissolved in binding buffer
(200 μl/peptides of 2 mg matrix) and added to approxi-
mately 5 mg of loosely pelleted TiO2 beads. The mixture
was incubated on a rotating wheel for 45 min. After
centrifugation the supernatant was again incubated with
fresh TiO2 beads as before. The beads were then washed
twice with 200 μl of binding buffer followed by 2 ×
200 μl of washing buffer. Finally the loaded beads were
filled into C8 Stage Tips and phosphopeptides were
eluted with 2 × 100 μl of a solution containing 40%
acetonitrile and 15% ammonia. The eluate was vacuum-
dried in an Eppendorf concentrator to ~20 μl and acid-
ified with TFA. The peptides were purified on C18 Stage
Tips [23] after dilution to 200 μl with 0.5% acetic acid.
LC-MS analysis
Phosphopeptide-enriched samples were analysed on a Q
Exactive high-performance Quadrupole Orbitrap mass
spectrometer (Thermo Fisher Scientific, Bremen, Germany)
[24] connected to an Easy-nLC 1000 nanoflow HPLC
system (Thermo Fisher Scientific). Peptides were sepa-
rated on a 50 cm column with an inner diameter of 75
μm filled with 1.8 μm C18 beads (Reprosil-AQ Pur,
Dr. Maisch GmbH, Ammerbuch, Germany) prepared as
described [25]. Peptides were eluted with acetonitrile in
0.1% formic acid using a gradient of 5-30% acetonitrile
in 95min, 30-60% in 30 min and 60-95% in 8 min at a
flow of 250 nl/min and a column temperature of 50°C
[25]. Mass spectra were acquired in a data-dependent
manner by automatically switching between MS and
MS/MS in a top 10 approach. The resolution was 70000
for full spectra and 17500 (both at m/z 200) for HCD-
derived fragments. The dynamic exclusion time was 30 sec.
Data analysis
To estimate the percentage of each protein in the total
identified shell proteome, raw-files used in a previous
study [17; method B] were re-analysed using the iBAQ
(intensity-based absolute quantification) method [19] as
implemented in MaxQuant version 1.3.9.21. Carbamido-
methylation was set as fixed modification, variable modi-
fications were acetyl (protein N-term), oxidation (M),
pyro-Glu (Q,E) and phospho (STY). Maximal FDR for
peptide spectral match, proteins and site was set to 0.01.
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length was 7 amino acids. The minimal score for modi-
fied peptides was 50 and the minimal delta score for
modified peptides was 17. A minimum of two sequence-
unique peptides was required for identification, except
for proteins that were identified with two or more
unique peptides previously in separately analysed acid-
soluble and acid-insoluble fractions [17]. In very few
cases new proteins were accepted with one unique pep-
tide if this peptide occurred several times in different
fractions and with an abundance of >0.01. The second
peptide option was activated to enable identification of
co-eluting peptides with very similar mass [26]. Two
miss-cleavages were allowed. The databases used were
Lottia FilteredModels (Lotgi1_GeneModels_FilteredMo-
dels1_aa.fasta.gz) and Lottia AllModels (Lotgi1_GeneMo-
dels_AllModels_20070424_aa.fasta.gz) [27] downloaded from
(http://jgi.doe.gov/), and a LOTGI subset of UniProtKB
v2013_7 entries downloaded from http://www.uniprot.org/.
These were supplemented with the reversed sequences
and common contaminants automatically and used for
quality control and FDR setting by MaxQuant. Phospho-
peptides were accepted if they occurred at least twice or
were confirmed by analysis of phosphopeptide-enriched
samples.
Peptide mixtures for enrichment of phosphopeptides
were prepared from three biological replicates prepared
according to method B of [17]. The acid-soluble and the
acid-insoluble matrix of each biological replicate were
used to prepare five technical replicates, resulting in 30
raw files that were evaluated together using MaxQuant
[26,28] version 1.3.9.21 with the same settings as above
with a minimum of one sequence-unique phosphopep-
tide only, but sequenced at least twice and in different
replicates. The decoy mode was set to reward in Max-
Quant. Phosphopeptide spectra were validated using the
MaxQuant Expert system, which provides additional
fragment annotations not included in the routine anno-
tation [29]. Criteria were the assignment of major peaks,
occurrence of uninterrupted y- or b-ion series of at
least four consecutive amino acids, preferred cleavages
N-terminal to proline bonds, the possible presence of
a2/b2 ion pairs, the presence of immonium ions, and
mass accuracy. In general only phosphopeptide identi-
fications with a localization probability of ≥0.75 were
accepted. However, in some cases adjacent residues,
such as X(n)-S-S-X(n), could not be resolved with the
fragmentation pattern of the respective phosphopeptides,
making it impossible to exactly localize the phosphory-
lation site. As a result, lower localization probability scores
were attributed to several residues. Such phosphopep-
tides were also accepted. Phospho sites were searched
for known kinase motifs using Phosida Motif Matcher
(http://www.phosida.com/) [30,31] and PhosphoMotif Finder(http://www.hprd.org/PhosphoMotif_finder) [32]. Most
sequence-unique peptides were identified several times
and site occupancy of phospho sites was estimated by
comparing the number of unmodified to the number of
phosphorylated forms of individual peptides.
Sequence similarity searches were performed with
FASTA (http://www.ebi.ac.uk/Tools/sss/fasta/) [33] against
current releases of the Uniprot Knowledgebase (Uni-
ProtKB). Other bioinformatics tools used were Clustal
Omega for sequence alignments (http://www.ebi.ac.uk/
Tools/msa/clustalo/) [34], InterPro (http://www.ebi.ac.uk/
interpro) [35] for domain predictions, and SignalP 4.1
(http://www.cbs.dtu.dk/services/SignalP/) [36] for signal
sequence prediction. Amino acid composition and theo-
retical pI were determined using the ProtParam tool
provided by the Expasy server (http://web.expasy.org/
protparam/) [37]. Intrinsically disordered protein struc-
ture was predicted using IUPred (http://iupred.enzim.
hu/) [38] and methods provided by the PredictProtein
2013 server (https://www.predictprotein.org/) [39,40].
GO categories for subcellular location were derived
from UniProt and Lottia database entries, signal se-
quence predictions and similarity to known proteins.
Results and discussion
Re-analysis and re-quantitation of Lottia shell proteins
with MaxQuant-implemented iBAQ
In search of the reasons for apparent differences in previ-
ously published Lottia shell proteomes [17,18] we noticed
that database searches were done using the AllModels
database in [18] while [17] used the FilteredModels data-
base containing entries supported by EST sequences.
Therefore we re-analyzed the raw-files produced previ-
ously for acid-soluble and acid-insoluble matrix prepared
according to method B [17] (also used to identify phos-
phoproteins in the present report) using a combination
of both databases and a subset of Uniprot containing
Lottia + gigantea entries. Furthermore, to determine the
approximate abundances of the identified proteins, the
iBAQ (intensity-based absolute quantification) method
[19] as implemented in more recent MaxQuant versions
was enabled in this search. The previously used [17]
emPAI method [41] belongs to the spectral count methods
based on counting the number of identified unique parent
ions per protein. In contrast, iBAQ and similar algorithms
are called intensity-based because they calculate the sum
of parent ion intensities of identified peptides per protein.
In both types of methods, the numbers of theoretically
possible peptides per protein for the protease used in sam-
ple preparation enter the equation to account for different
protein lengths and distribution and frequency of cleavage
sites. Comparison of the two different types of methods
show a higher accuracy of the intensity-based methods,
including iBAQ (for instance [42]), indicating that they
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method in its original form [41] as we used it has become
somewhat obsolete because of the recent progress in tech-
nology. For instance, modern mass spectrometers and the
associated software provide high-confidence identifica-
tions of much longer peptides than previously possible.
Consequently these long peptides are not included into
emPAI calculations [41], but are included in iBAQ
calculation.
Irrespective of the quantitation method accurate quan-
titation certainly also depends on the quality and com-
pleteness of the available sequence databases. Sequences
not contained in the database can be neither identified
by high-throughput mass spectrometry-based proteomic
analysis nor quantitated. The same applies to sequences
having no cleavage sites for the protease used in sample
preparation. Faulty combination of sequences belonging to
different proteins into one database entry or unnoticed
faulty allocation of fragments of one protein to different
database entries can all bias quantitation results. Finally,
the abundance of proteins bearing many posttranslational
modifications will be underestimated if the modification is
not included in the analysis. In spite of these caveats we
believe that routine quantitation of proteins in in-depth
proteomic studies may be a useful tool to identify possible
functionally important proteins for further study. We
express the abundances as percentage of the identified
proteome, obtained by normalizing the iBAQ intensities
to the sum of all intensities. While the decision what to
count as a major protein or a minor protein still remains
arbitrary, it may now be more comprehensible to the
reader and will possibly facilitate the decision of which
proteins to choose for further studies.
The results of this new search (Additional file 1:
Table S1) now includes all proteins published by [18]
and contains 496 proteins/protein groups. Of these,
382 protein/protein group identifications were accepted
(Additional file 2: Table S2) according to the rules stated
in the Materials and Methods section. Twenty-three pro-
teins were identified in the AllModels database only or in
combination with the UniProt entries, including several
very abundant ones (Table 1). Many groups contained
several AllModels entries testifying to the high redun-
dancy in this database. The corresponding MaxQuant
table with protein data is contained in Additional file 1
(Additional file 1: Table S1), which also includes identi-
fications not accepted. These were, for instance, identi-
fications with only one single peptide with low scores or
insufficient sequence coverage. The peptide data of the
more than 4000 sequence-unique peptides, including
peptide sequences and scores, are shown in Additional
file 3 (Additional file 3: Table S3).
Quantitation with iBAQ showed that only 18 proteins/
protein groups of a percentage of more than 1% of theidentified proteome already constituted approximately
82% of the entire identified proteome (Table 1). This
group comprised two very abundant (>1%) proteins not
contained in the FilteredModels database, the Asp-, Gly-,
Lys- and Ser-rich peroxidase-like protein-1 (DGLSP_
LOTGI/Lotgi1|162078) and the Gly- and Ser-rich protein-
1 (GSP1_LOTGI/Lotgi1|239214) [18]. If a percentage of
larger than 0.1% was chosen as a threshold, a total of 57
proteins (Table 1) amounted to approximately 98% of the
total identified proteome. These included CCD2 (coiled-
coil domain-containing protein 2; Lotgi1|234936), the
perlwapin-like protein PWAP_LOTGI/Lotgi1|239121, and
the EGF-like domain-containing protein 2 (ELDP2/Lotgi1|
167423) [15], which were contained in the AllModels
database but not in the FilteredModels database. Almost
all proteins also identified in [18] were contained in this
fraction of the proteome. Exceptions were the EF-hand
calcium-binding domain-containing protein 1 and 2
(EFCB1/B3A0Q5, EFCB2/B3A0R9), and Threonine-rich
protein LUSP-15/TRP/B3A0R4, which apparently belonged
to the minor components of the identified proteome
(Additional file 2: Table S2). However, we also identified
several entries with a high similarity to EFCB2 based on
sequence overlaps with sequence identities of 43-90%
(Figure 1). Taken together, this protein family constituted
slightly more than 0.1% of the identified proteome.
In agreement with a previous study [18] the major pro-
teins comprised three peroxidase-like proteins (Table 1)
including the most abundant protein Lotgi|162078/
DGLSP_LOTGI. Peroxidases are a large and widespread
family of enzymes catalysing redox reactions using a
variety of electron donors and acceptors, including
organic molecules. Peroxidases have been implicated
previously in mollusc shell formation [43]. Possibly they
are responsible for the sclerotization of the periostra-
cum [44-46], a proteinaceous layer confining the mantle
cavity before the start of mineralization. As discussed
previously [18] one may hypothesize that peroxidases
function in stabilization of the newly secreted matrix by
cross-linking some of its components. Another major
protein, the abundance of which was noticed only using
the AllModels database because the FilteredModels only
contained a small fragment, was Lotgi1|166131. In this
protein a long stretch of sequence with predicted disor-
dered structure is followed by a predicted superoxide
dismutase domain. Superoxide dismutases are a family
of enzymes with widespread subcellular distribution that
remove superoxide, a normal aerobic metabolite. One
reaction product of superoxide dismutases is H2O2, a
substrate of peroxidases.
In general, very little is known about the possible func-
tions of shell matrix proteins, but in some cases similar-
ities to known proteins and predicted domain structures
may provide some clues for further studies. Predicted
Table 1 Fifty-seven proteins with an individual percentage of equal to or larger than 0.1% constitute 98% of the total identified proteome




Aspartate-, glycine-, lysine- and serine-rich protein/B3A0P1/peroxidase-like protein 1; domain:
haem_peroxidase (~aa40-675); 20% G, 12% S; pI 4.96; GO: extracellular; DS: most of aa680-1870
Lotgi1|162078 DGLSP_LOTGI2 16.71 ++
Proline-rich protein 1/B3A0Q1; 11% A, 13% P; pI:9.72; GO: extracellular; DS: C-terminal 15aa Lotgi1|2354971 PRP1_LOTGI2 12.28 (+)
Glycine- and methionine-rich protein/B3A0R1; 12% A, 20% G, 10% L, 18% M, pI:11.24; GO: extracellular; DS: aa125-225 Lotgi1|2391741 GMP_LOTGI2 9.14
Glycine- and Serine rich protein-1/B3A0P6; 10% A, 20% G, 13% S; pI 9.0; GO: extracellular; DS: ~aa67-84 (18aa) Lotgi1|239214 GSP1_LOTGI2 6.82 (+)
Peroxidase-like protein 2/B3A0P3; domains: haem_peroxi-dase (~aa666-1124); 13% G, 11% S; pI 8.52; GO: extracellular;
DS: ~aa1-620, aa1197-1492
Lotgi1|2328171 PLSP2_LOTGI2 6.80 ++
Glycine-rich protein/B3A0R2; 10% A, 16% G, 12% M, 10% L; pI 9.87; GO: extracellular; DS: aa127-145 (19aa) Lotgi1|2391701 GRP_LOTGI2 5.91
Uncharacterized shell protein 5/B3A0Q0; 13% A, 11% R, 11% L; pI 10.32; GO: extracellular; DS: short stretches especially
in C-terminal half
Lotgi1|2388311 USP5_LOTGI2 5.11
Coiled-coil domain-containing protein 1/B3A0Q3; domain: coil; 31% D; pI 3.55; GO: extracellular; DS: short stretches all
over aa27-394
Lotgi1|2334201 CCD1_LOTGI2 3.49 ++
Similar to blue mussel shell protein (BMSP)/similar to collagen α4 (VI); domains: VWA; 11% I; pI 8.33; GO: extracellular;
DS: none
Lotgi1|1406601 Lotgi1|1731392 2.81
Uncharacterized shell protein 13/B3A0R3; 10% G; pI 8.32; GO: extracellular; DS: ~aa180-291 Lotgi1|2348851 USP13_LOTGI2 2.13
Uncharacterized shell protein 16/B3A0R5; pI 9.63; GO: extracellular; DS: none Lotgi1|2310461 USP16_LOTGI2 2.01
Proline-rich protein 2/B3A0R8; 16% P; pI 9.98; GO: extracellular; DS: short stretches especially in aa161-186 Lotgi1|2305101 PRP2_LOTGI2 1.67
Glycine-, glutamate-and proline-rich protein/B3A0P5; domain: Lysozyme_like (~aa240-415); 12% Gly; pI 5.08; GO:
extracellular; DS: aa73-137, aa201-218
Lotgi1|2313111 GEPRP_LOTGI2 1.45 +
Methionine-rich protein/B3A0R7; 10% N, 11% P; pI 9.62; GO: extracellular; DS: ~aa50-400 Lotgi1|1732001 MRP_LOTGI2 1.43
Uncharacterized shell protein 26/B3A0P4/BMSP-like; 18% G, 12% S, 10% T; pI 9.11; GO: extracellular; DS: small segments
scattered over entire sequence
Lotgi1|2385261 USP26_LOTGI2 1.42 +
Uncharacterized shell protein 8/B3A0Q4; 11% P, 10% Y; pI 9.71; GO: extracellular; DS: short regions interspersed
throughout the sequence
Lotgi1|2282681 USP8_LOTGI2 1.22 +
Uncharacterized protein; 10% Q (C-term), 11% P; pI 9.67; GO: none; DS: : small segments scattered over entire sequence Lotgi1|1581131 1.19
Uncharacterized/similar to superoxide dismutase; domain: SOD; 12% P, 10% Q; pI 9.30; GO: intracellular/extracellular;
DS: ~aa20-450; SOD:~aa480-635
Lotgi1|166131 Lotgi1|1016111 1.09 +
SCP domain-containing protein 2/B3A0P8; domain: CAP (~aa145-310); pI 9.56; GO: extracellular; DS: ~aa16-155 Lotgi1|2332001 SCP2_LOTGI2 0.97
Similar to nacrein-like protein/putative carbonic anhydrase 1/B3A0P2; domain: α-carbonic anhydrase; pI 6.44;
GO: extracellular; DS: none
Lotgi1|2380821 CAH1_LOTGI2 0.96
Putative carbonic anhydrase 2; aa190-632 100% identity to CAH2/B3A0Q6; domain: α-CA (~aa85-411); 11% R, 13%
D, 13% G; pI 5.87; GO: extracellular; DS: aa415-633
Lotgi1|2391881 CAH2_LOTGI2 0.88
Uncharacterized protein; 10% A, 12% L; pI 9.77; GO: extracellular; DS: few to none Lotgi1|2310091 0.87
Uncharacterized protein; domain: CBM_14 (chitin-binding)/peritrophin A (~aa18-87); pI 6.65; GO: extracellular; DS: none Lotgi1|1731381,2 0.87



















Table 1 Fifty-seven proteins with an individual percentage of equal to or larger than 0.1% constitute 98% of the total identified proteome (Continued)
Uncharacterized shell protein 4/B3A0P9; 10% S, 12% Y; pI 8.89; Go: extracellular; DS: possibly short C-tern segment Lotgi1|2361831 USP4_LOTGI2 0.77
Glycine and tyrosine-rich protein/B3A0Q2; 14% G, 13% T; pI 5.43; GO: extracellular; DS: most of the sequence Lotgi1|2356211 GTRP_LOTGI2 0.71
aa151-448 96% identity to coiled-coil domain-containing protein 2/B3A0Q7; 10% D, 20% G (GM/GGG-rich C-terminus
(~aa430-630); pI 3.77; GO: extracellular; DS: most of aa290-410
Lotgi1|234936 CCD2_LOTGI2 0.67
Uncharacterized protein; domains: antistasin, WAP; 16%C,11% P, pI 5.62; GO: extracellular; DS: none Lotgi1|2391251 Lotgi1|226725 0.66
Uncharacterized protein/glycosidase 2; domain: DUF187; similar to GEPRP_LOTIA (37% identity); pI 4.76; GO:
extracellular; DS: ~aa78-130
Lotgi1|1749201,2 0.64 +
Uncharacterized protein/similar to ER aminopeptidase; domain: peptidase_M1, ERAP1_LIKE_C; pI 8.94; GO: ER/Golgi/ext.
plasma membrane; DS: none
Lotgi1|1407861 Lotgi1|225855 0.61
SCP domain-containing protein 1/B3A0P7; domain: CAP (aa143-305); 11% S; pI 9.21; GO: extracellular; DS: ~aa20-110 Lotgi1|2331991 SCP1_LOTGI2 0.53
Uncharacterized Gly-rich protein; 12% N, 22% G; pI 9.54/9.30; GO: extracellular; DS: ~aa40-200 (275200) Lotgi1|2394471 Lotgi1|175200 0.47
Similar to chorionic proteinase inhibitor/perlwapin-like; domains: WAP (5x); aa1-125 99.6% identity to B3A0S1;




Uncharacterized protein; pI 9.49; GO: none; DS: none Lotgi1|2343871 0.38
Proline-rich protein 3/B3A0S4; 10% N, 11% G, 13% P; pI 9.56; GO: extracellular; DS: few short segments Lotgi1|2379961 Lotgi1|172116
PRP3_LOTGI2
0.34
EGF-like domain-containing protein 1 (aa170-682 of entry)/B3A0R6; domains: EGF (aa241-277), zona _pellucida (ZP;
aa284-534); pI 5.80; GO: extracellular; DS: ~aa525-620
Lotgi1|2355481 ELDP1_LOTIA2 0.27
Peroxidase-3/B3A0Q8; domain: haem_peroxidase (aa531-1077); 13% N; pI 7.5; GO: extracellular; DS: 26-381 Lotgi1|2328181 Lotgi1|99809
PLSP3_LOTGI2
0.26
Uncharacterized protein/LUSP_10; 16% A, 17% D; pI 3.82; GO: extracellular; DS: most of the sequence Lotgi1|1636371,2 0.25
Uncharacterized protein; Pro/Ala- and His-rich motifs in C-term; pI 8.78; GO: extracellular; DS: short segments scattered
over entire sequence
Lotgi1|2333971 Lotgi1|163339 0.24





Uncharacterized; domains: VWC/pacifastin; 13% C, 12% D, 11% S; pI 3.87; GO: extracellular; DS: none Lotgi1|2308541 Lotgi1|99757 0.23
Uncharacterized Gln-rich protein; 26% Q, 13% L, 12% T; pI 4.02; GO: extracellular; DS: ~aa40-320 Lotgi1|1593311 0.22
Uncharacterized Pro-rich protein; 15% P; pI 9.50: GO: extracellular; DS: aa32-416 Lotgi1|1740031 0.22
Uncharacterized protein/LUSP-18; 15% P, 15% T; pI 5.73; GO: extracellular; DS: ~aa18-557 Lotgi1|2356101,2 0.20
EGF-like domain_containing protein 2/B3A0S3; domains: EGF (aa73-109), ZP (aa116-370); pI 4.9; GO: extracellular;
DS: few (aa364-386,403-425)
Lotgi1|167423 ELDP2_LOTGI2 0.19
Uncharacterized protein/Similar to PIF; 41% identity to PIF_PINFU aa427-526; domain: ConA_like_lectin; pI 8.91;
GO: extracellular; DS: none
Lotgi1|2375101 Lotgi1|171086 0.16
Uncharacterized protein/LUSP-14; domain: chitin_binding_3; pI 8.77; GO: extracellular; DS: aa225-251 Lotgi1|2267261 Lotgi1|2391292 0.16 +
Uncharacterized protein; 28% identical to PIF_PINFU: domains: VWA, chitin-binding, ConA_like_lectin; pI 5.15;





















Table 1 Fifty-seven proteins with an individual percentage of equal to or larger than 0.1% constitute 98% of the total identified proteome (Continued)
Uncharacterized Gln-rich protein; domain: Sushi/SCR/CCP (aa158-212); 19% Q, 11% P; pI 9.19; GO: extracellular; DS: most
of the sequence
Uncharacterized protein; aa1-138 100% identity to ASRP/B3A0S2; 10% A, 10% N, 19% D, 11% V; pI 3.73 acid C-term half);
GO: extracellular; DS: aa43-232
Lotgi1|2383581 ASRP_LOTGI2 0.14 +
Uncharacterized protein; 13% S; pI 4.43; GO: extracellular; DS: aa47-338 Lotgi1|1710841 0.11 +
Perlustrin-like/B3A0Q9; 43% identity to PLS_HALLA; domain: IGFBP_N; 11% C, 11% E; pI 4.05; GO: extracellular; DS: none Lotgi1|2389701 PLSLP_LOTGI2 0.11
Uncharacterized protein; 10% Q, 10% P, 11% S; pI 9.79; GO: extracellular; DS:~aa90-928 Lotgi1|1583161 0.10
Uncharacterized protein; domain: SOUL_haem_binding; 13% L; pI 6.96; GO: extracellular; DS: none Lotgi1|2050301 Lotgi1|237594 0.10
Uncharacterized protein; 11% E, pI 4.32; GO: none (transmembrane?); DS: aa426-669 and smaller segments Lotgi1|1540201 0.10 ++
Uncharacterized shell protein 22/B3A0S0; 21% Q, 18% P; pI 8.43; GO: extracellular; DS: most of the sequence Lotgi1|2366901 USP22_LOTGI2 0.10
Uncharacterized protein/LUSP-20; domains: chitin_binding CBM_14/peritrophin A (aa384-504); 13% T; pI 6.79;
GO: extracellular; DS: most of ~ aa60-380
Lotgi1|2395741,2 0.10
+, less than three peptides phosphorylated; ++, three or more phosphopeptides; (+), not confirmed with phosphopeptide-enriched samples. DS, predicted disordered structure. 1, previously identified by Mann et al.,



















Lotgi1|157683   1 MKLALVL-VAVVLVVN---VE------GWGWRAPRIR--IPPIRIPRIPI
Lotgi1|230732   1 MKLALVL-VAVVLVVN---AE------GWGWRAPRVS--WPRIRIPRIGI
Lotgi1|230731  1 MKLALIL-VAVVLVVN---VE------GWRLTRRTSRFTIPRFPIPRFPT




Lotgi1|239519      1  MKIGLILLVAVIT--MCQEAE/////////////////////////////
Lotgi1|157683   39 PRIPLPRLPRI---PIPRIPWGKRDVQQA-------AAAEDGVLSDDELK
Lotgi1|230732   39 PPVTIPG---------IRIT---RDVREAEGDAAFNAAAEDGVLSDDEIK
Lotgi1|230731   41 PCYPISRFPKPRKPSIPRMPWGKRNVREAEGDAGFKAAAEDGVLSNDEIK
Lotgi1|157689  33 --------------IQLRMPCGKKDVRQADNDAAFKAAAEDGVLSDDEIK
EFCB2/B3A0R9 42 PFVIGA--------------VGKRQAGDAEFQAKYNAAAEDGVFTDEEIK
Lotgi1|231426  83 PIVIRA--------------FGKRQAGDAEFQAKYNAAAEDGVFTDEEIK
Lotgi1|157690   81 -----------------GWLWGKRDVRNADFDAAYNAAAEDGVFTDDEIK
Lotgi1|239519 130 /////////////WWLRKRWSGKKDVRDADFDAAYNAAAKDGVFTDEEIK
Lotgi1|157683  79 SILGVADEGLAEVYEVYDVNEDGVITVAEFEAVSSILENMQGEEEGQ--
Lotgi1|230732   77 SVLGVADKDLAGFKVLYDVNSDGKITVEEYRAVTATLAN-AGDKEN---
Lotgi1|230731   91 SVFGVKDEDLADFYDLYDVNGDGKITVEEYQSVTTILAN-AGDKEN---
Lotgi1|157689   69 SVLGVADEDLADFYDLYDVNGDEKITVEEYESVTTVLAN-AGDKEN---
EFCB2/B3A0R9 78 SVFGVDDNGFVEFKATYDVDGDGVVQVEEYETVVELTENLAG-------
Lotgi1|231426    119 SVFGVDDNGLVEFKATYDVDGDGVVQVEEYETVVELTENLAG-------
Lotgi1|157690    114 SVFGVDVD---EFKAAYDVNDDGVVKVLEYELVNKVNQDE---------
Lotgi1|239519 167 SVFGVDENGFAEFKENFDVNEDGVVEVEEYETLASNENKVNETKEKRWK
Figure 1 Alignment of EFCB2 to similar sequences. Sequences covered by MS/MS-sequenced peptides are shown in red. Slashes in the
sequence of Lotgi1|239519 indicate an insert between signal peptide and the EFCB2-like sequence that does not occur in the other entries. All
shown entries were part of protein groups containing other similar sequences due to the high redundancy of the AllModels database.
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http://www.proteomesci.com/content/12/1/28domain structures, GO terms for subcellular location,
unusual amino acid composition features (amino acids
representing ≥ 10% of the sequence) and theoretical
isoelectric point for major identified Lotgi entries are
included in Table 1. Extremely acidic matrix proteins
(pI below 4.5) have found much interest in biomineral-
ization research because of the possibility of direct
interaction with the positively charged biomineral cations
and have been hypothesized to act as nucleation sites
involved in crystal formation [47]. The group of 57 pro-
teins with an abundance of >0.1 includes eight of such
uncharacterized unusually acid proteins (Table 1) that
may deserve to be studied in more detail. Many proteins
isolated from biominerals contain sequence regions of
intrinsically disordered structure, a feature that is impli-
cated in protein-protein interaction and mineral binding
[48,49]. Table 1 includes several proteins with extended
sequence regions of predicted disordered structure, such
as the peroxidase-like protein-1 (DGLSP_LOTGI), the
methionine-rich protein MRP_LOTGI, peroxidase_like 3
(PLSP3_LOTGI), and the uncharacterized proteins in
Lotgi1|163637, 159331, 235610, 234884, 171084, 158316,236690, and 239574. In two sequences both features,
unusual acidity and predicted long-range structural dis-
order, coincide (Lotgi|159331, 171084). However, like all
predicted features, predicted structural disorder needs
experimental validation before far-reaching conclusions
can be drawn.
Sometimes predicted domains strongly indicate in-
volvement of the respective protein in biomineraliza-
tion events. The putative carbonic anhydrases encoded
in Lotgi|238082/CAH1 and Lotgi|239188/CAH2 and
discussed previously [18] may be important for carbonate
ion delivery. Also of special interest are proteins containing
chitin-binding domains, such as Lotgi1|226726, 228264,
and 239574. Many mollusc shells contain chitin-based
extra-crystalline scaffolds and chitin-binding proteins
may be important for organizing such scaffolds or may
mediate interactions between chitin and the calcified
matrix [50]. However, for most proven and putative shell
matrix proteins the function remains unknown at present.
Most of the identified proteins were only minor, or
trace, components that may not have a function in bio-
mineralization. However, it should be emphasised that
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(0.006% of the Lottia shell proteome; Additional file 2:
Table S2), was recently identified as a Golgi apparatus
kinase responsible for the phosphorylation of many
secreted proteins, including proteins important for bio-
mineralization [3,4]. This kinase is also secreted to some
degree, may be active in the extracellular space [5], and
may enter biominerals in the company of its substrates.
Of course this does not imply any function within the
matrix but may explain its presence there. Other exam-
ples of the possible importance of trace components for
biomineral formation are the sea urchin spicule proteins
P58-A and P58-B. The extracellular domains of these
predicted transmembrane proteins were detected as
minor components in sea urchin spicule matrix [51] and
both were subsequently shown by knock-down experi-
ments to play an essential role in sea urchin larval skele-
togenesis [52]. Also among the trace components are
proteins known to have a predominantly intracellular
location, such as cytoskeletal components and cytosolic
enzymes (Additional file 2: Table S2). We think that
these proteins do not have a function in biominerali-
zation. However, even trace components with a well-
defined intracellular role, such as ubiquitin (now also
known to occur in the extracellular space, however
[53]) may have a true role in biomineralization, such as
in the matrix of the Pinctada fucata shell prismatic
layer [54]. Finally it should be considered that the
number of up-regulated genes, for instance after shell
damage [55], is usually much larger than the number
of major proteins identified in shell matrices. Possibly
many of the trace proteins reflect regulatory or cata-
lytic processes involved in the mineralization event at
some point.
The phosphoproteome
Because of the low number of different proteins in the
shell matrix and because the HCD (higher energy colli-
sional dissociation) fragmentation method used in the
previous shell proteome analysis [17] enables phospho-
peptide analysis at high resolution and mass accuracy in
the LTQ Orbitrap Velos [56,57] without the need for
neutral loss-dependent MS3 or multistage activation [58]
used previously with CID fragmentation, we included phos-
phorylation as a variable modification in this re-analysis.
The results indicated (Additional file 1: Table S1) that
several major and a few minor proteins were phosphor-
ylated to a variable extent. These preliminary results
were validated by analysis of phosphopeptide-enriched
samples of shell matrix proteins (Additional file 4:
Table S4). Thirteen of these were confirmed by analyz-
ing phosphopeptide-enriched fractions. Three more
were identified only in phosphopeptide-enriched samples
(Additional file 4: Table S4), yielding a total of 20phosphoproteins. The MaxQuant phosphopeptide output
table is shown in Additional file 5: Table S5. Nine major
proteins with a percentage of more than 1% of the iden-
tified protein and five with a percentage between 0.1%
and 1% (Table 1) were identified as phosphoproteins.
Simultaneous determination of phosphorylated and non-
phosphorylated versions of the phosphopeptides in the
general survey without prior enrichment enabled an ap-
proximate estimation of site occupancy (Additional file 4:
Table S4), which was very low in most cases. Site occu-
pancy in the group of major proteins was highest in
GEPRP/B3A0P5 and the uncharacterized protein of
Lotgi1|154020. While GEPRP contained only two closely
spaced phosphorylation sites, Lotgi1|154020 contained
four sites in three peptides (Additional file 4: Table S4).
This high site-occupancy strongly indicates that phosphor-
ylation of these proteins may be functionally important.
Three proteins, DGLSP/B3A0P1, PLSP2/B3A0P3 and
CCD1/B3A0Q3 yielded more than three phosphopeptides
with variable site-occupancy (Additional file 4: Table S4).
Of these, Coiled-coil domain-containing protein 1 (CCD1)/
B3A0Q3 was already shown to be extremely acidic previ-
ously [18], a feature that is enhanced by phosphorylation.
This may be taken as a further indication of a very import-
ant, but as yet not understood, role of this protein in Lottia
shell assembly.
Taking into account the number of phosphorylation
sites and site occupancy, CCD1/B3A0Q3 may be consid-
ered as the major phosphoprotein of the Lottia gigantea
shell matrix. We want to point out, however, that densely
phosphorylated proteins with highly repetitive sequences,
such as dentin phosphoryn, which contains almost
exclusively aspartic acid, asparagine and phosphoserine
[2], require special techniques to be identified and may
be missing from our analysis.
A search for sequences including phospho sites for
known kinase motifs indicated that approximately one
third (16 of 46) of the unique S/T phospho sites comply
with the Fam20C recognition site S-x-E or related motifs
(S/T-x-E/D/pS/pT) [3,4]. This percentage is in good agree-
ment with the approximately 24% of human secreted
phosphoproteins modified at the serine of the canonical
FAM20C motif S-x-E [6]. However, much less is known
about phosphorylation in invertebrate secreted proteins
and the kinases involved. Therefore it is unknown whether
these recognition sites are conserved between vertebrates
and invertebrates. Five of the sites identified are in agree-
ment with the typical casein kinase 2 motif S-x-x-E also
modified in the mammalian mineralization-inhibiting
protein osteopontin, and ten sites comply with the
casein kinase 1 motif (D/E)n-x-x-S/T [1] indicating that
secreted or membrane-bound kinases with casein-
kinase-like activity are involved. Evidence for such
kinases is summarized in [5,6].
Figure 2 An example of different partially occupied phospho
sites in one sequence. This peptide occurs in the sequence of
DGLSP/B3A0P1/Lotgi1|162078 (Aspartate-, glycine-, lysine- and
serine-rich protein, aa324-335). A, peptide variant with phosphotyrosine
identified by an uninterrupted series of y-ions for the rest of the
sequence and the very intense diagnostic pY immonium ion at m/z
216.042. Expert annotations [29] were omitted, except for the major
peak at m/z 120.0809 (phenylalanine immonium ion), to keep the
spectrum clear. The doubly charged peptide ion was measured
with a mass error of −0.014 ppm. PEP and phosphphorylation site
localization probability were calculated by MaxQuant to be 8.96e-93
and 0.999. B, this time S4 was determined as the phosphorylation site
in an uninterrupted series of y-ions from y1 to y11. The mass error
was −0.490 ppm, PEP was 1.16e-54 and the localization probability was
1.00. Major peaks at m/z 120.0809 and 136.0756 were annotated by
the MaxQuant Expert system as the phenylalanine immonium ion
and the a1-ion. A major peak at m/z 192.1016 was not annotated.
Expert annotations of most of the minor peaks are omitted for clarity.
C, a third phosphorylation site at S8 was detected with a localization
probability of 1.00 in still another variant of this peptide measured with
a mass error of 0.531 ppm and with a PEP of 3.28e-164. Again, most
expert annotations are omitted. *, ions showing a loss of H3PO4 from
phosphoserine. Y-ions are shown in red, b-ions are shown in blue, b-or
y-ions with a loss of ammonia or water are in orange, the a2 ion is
shown in light blue, black identifies ions without annotation unless the
annotation is shown on top of the peak.
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Our approach to proteomes of invertebrate biominerals
consists of washing the biominerals with hypochlorite in
a less stringent way than proposed recently [59] to pre-
serve extra-crystalline matrix components, and to iden-
tify as many proteins as possible after in-gel digestion of
slices of the entire gel [17] irrespective of staining inten-
sity, or after in-solution digestion using filter-aided sample
preparation (FASP) [20]. Included in protein identification
is quantitation, which was done using exponentially modi-
fied protein abundance index (emPAI) [41] previously
[17], but was recently superseded [60] in favor of the more
accurate automated iBAQ method [19] as implemented in
more recent versions of MaxQuant. We believe that this
approach is well suited to identify candidates for func-
tional matrix proteins, most likely found among the most
abundant components, while retaining all of the infor-
mation about trace components, irrespective of whether
these may have a function in biomineralization or not, and
irrespective of whether they are intra-crystalline or belong
to the extra-crystalline matrix. Proteins predominantly
located intracellularly, such as cytoskeletal components,
ribosomal proteins, proteasome subunits or cytoplasmic
enzymes, belong to the minor components of the Lottia
shell proteome (Additional file 2: Table S2) constituting
only an insignificant fraction of the total. However, the
identification and quantitation of such proteins may also
depend in some way on the biomineral examined, the
instrumentation used, and the washing procedures applied
to the shell and we agree with others [59,61] that the mere
Mann and Edsinger Proteome Science 2014, 12:28 Page 11 of 12
http://www.proteomesci.com/content/12/1/28presence of such proteins in the matrix sample does
certainly not imply a function.
The group of major proteins also contains several
phosphoproteins. Those yielding high-occupancy phos-
pho sites and/or many phosphorylated sequence-unique
peptides were already identified without prior phospho-
peptide enrichment in a general survey. However, subtle-
ties such as the occurrence of different sites with high
localization probability within one peptide sequence
(Figure 2) are more likely detected with the higher copy
numbers usually provided by phosphopeptide-enriched
samples. Nevertheless, inclusion of phosphorylation
among the variable modifications in general studies of low
complexity proteomes may give an overview of what to
expect with phosphopeptide-enriched samples and may
provide a rough estimate of phospho site occupancies.
Additional files
Additional file 1: Table S1. This table shows the complete list of
identified proteins/protein groups including identifications that were not
accepted following closer inspection, for instance because only one
peptide was sequenced with insufficient sequence coverage. The table
includes relevant parameters as, for instance, additional accession
numbers for protein groups, scores or molecular weight of predicted
proteins. Due to the simultaneous use of two databases and the high
redundancy of the AllModels database some few groups contained so
many similar entries that the Excel program created extra cells to
accommodate all data. This disrupted the regular pattern of lines and
columns of the sheet. However, the start of new groups is easily
recognizable by >jgi|Lotgi1 followed by the accession code.
Additional file 2: Table S2. In contrast to Table S1 this table only lists
accepted protein/protein group identifications.
Additional file 3: Table S3. This MaxQuant output table shows all
peptides leading to identifications in Table S1, their sequences, scores, and
other relevant parameters. Due to the simultaneous use of two databases and
the high redundancy of the AllModels database some peptides appeared in
so many similar entries that the Excel program created extra cells to
accommodate all data. This disrupted the regular pattern of lines and columns
of the sheet. However, the start of new peptide entries is clearly recognizable
by the peptide sequence. Peptides appear in alphabetical order.
Additional file 4: Table S4. List of identified and accepted
phosphopeptides and phosphoproteins from the general proteomic
survey and from analysis of phosphopeptide-enriched samples.
Additional file 5: Table S5. This table essentially contains the
MaxQuant Phospho(STY)Sites output file with all relevant parameters
such as sequences, scores, and localization probabilities.
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